Enanta Pharmaceuticals, Inc. (ENTA) — SEC filings
Recent SEC filings for Enanta Pharmaceuticals, Inc. — 10-K, 10-Q, 8-K, proxy statements, and insider transactions.
| Form Type | Filing Date | Accepted Date |
|---|---|---|
| 8-K | 2026-07-02 | 2026-07-02 |
| 8-K | 2026-06-23 | 2026-06-23 |
| 8-K | 2026-06-18 | 2026-06-18 |
| S-8 | 2026-05-13 | 2026-05-13 |
| 10-Q | 2026-05-13 | 2026-05-13 |
| 8-K | 2026-05-11 | 2026-05-11 |
| SC 13G/A | 2026-03-26 | 2026-03-26 |
| 8-K | 2026-03-26 | 2026-03-26 |
| 4 | 2026-03-13 | 2026-03-13 |
| 4 | 2026-03-13 | 2026-03-13 |
| 4 | 2026-03-13 | 2026-03-13 |
| 4 | 2026-03-13 | 2026-03-13 |
| 4 | 2026-03-13 | 2026-03-13 |
| 4 | 2026-03-13 | 2026-03-13 |
| 8-K | 2026-03-12 | 2026-03-12 |
| EFFECT | 2026-02-20 | 2026-02-23 |
| 4 | 2026-02-13 | 2026-02-13 |
| 4 | 2026-02-13 | 2026-02-13 |
| 4 | 2026-02-13 | 2026-02-13 |
| 4 | 2026-02-13 | 2026-02-13 |
Recent SEC filings.